搜索临床试验以:Enasidenib甲磺酸盐
总计1681个结果
-
Dana-Farber Cancer InstituteGenentech, Inc.; Eisai Inc.终止
-
Kent Robertson完全的
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis完全的
-
Daiichi Sankyo主动,不招人复发/难治性外周 T 细胞淋巴瘤 | 成人 T 细胞白血病/淋巴瘤美国, 西班牙, 日本, 英国, 大韩民国, 法国, 意大利, 澳大利亚, 加拿大, 德国, 荷兰, 台湾
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Celgene招聘中急性髓性白血病 | 慢性粒单核细胞白血病 | 原始细胞过多的骨髓增生异常综合征 | IDH2基因突变 | 复发性高危骨髓增生异常综合征 | 难治性高危骨髓增生异常综合征 | 破坏 20-30% 的骨髓有核细胞美国
-
Guangzhou Institute of Respiratory DiseaseJiangsu HengRui Medicine Co., Ltd.未知
-
University of OxfordJohns Hopkins Bloomberg School of Public Health; University of Otago; Patan Academy of Health...完全的
-
The First Affiliated Hospital of Zhengzhou University未知
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Hikma Pharmaceuticals LLC招聘中
-
Imperial College LondonUniversity of Sheffield; Medical Research Council; University of Cambridge; National Institute for...主动,不招人
-
National Taiwan University HospitalNational Cheng-Kung University Hospital; Far Eastern Memorial Hospital; Tri-Service General Hospital 和其他合作者终止
-
Shanghai Zhongshan HospitalChanghai Hospital; Fudan University; Huashan Hospital; Ruijin Hospital; Shanghai Changzheng Hospital未知Method of Differentiating Benignancy and Malignancy, Grading and Staging for GIST中国
-
Dana-Farber Cancer InstituteNovartis完全的
-
Università degli Studi di Brescia完全的
-
University of California, Los AngelesNovartis Pharmaceuticals完全的